Skip to main content

Table 2 Relationship between TIMP-1 tumour cell immunoreactivity and treatment efficacy.

From: Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

 

TIMP-1 expression

 
 

Negative (n = 92)

Positive (n = 14)

p

CA-125 GCIG Response

  

0.53

Response (n = 93)

80 (87%)

13 (93%)

 

Non-response (n = 13)

12 (13%)

1 (7%)

 
  1. Correlation between TIMP-1 expression and CA125 response (N = 106)